Primary Record
Selurampanel
- In stock
- 8,627 g
- Purity
- 98.5 %
- CAS
- 912574-69-7
Compound Identifiers & Properties
- CAS
- 912574-69-7
- PubChem CID
- 45381907
- SMILES
- CC(C)C1=C(C=C2C(=C1)NC(=O)N(C2=O)NS(=O)(=O)C)C3=CC=NN3C
- Canonical SMILES
- CC(C)c1cc2[nH]c(=O)n(NS(C)(=O)=O)c(=O)c2cc1-c1ccnn1C
Names & Synonyms
- Selurampanel
- selurampanelum
- Selurampanel [INN]
- BGG492
- 7WG1MR7DAR
- UNII-7WG1MR7DAR
- 912574-69-7
- BGG-492
- RefChem:931600
- BGG 492a
- D02RVN
- SELURAMPANEL [WHO-DD]
- BGG 492
- DTXSID00238467
- BGG-492A
- orb1695232
- SCHEMBL1660562
- CHEMBL3545042
- SCHEMBL30259242
- DTXCID20160958
- Selurampanel-[13C,15N2,d3]
- MCECSFFXUPEPDB-UHFFFAOYSA-N
- AKOS032946688
- BLP-004221
- DB12367
- SB17404
- TS-08793
- AMPA antagonist (oral, epilepsy), Novartis
- DB-343729
- HY-105860
- CS-0026799
- NS00073383
- A1241330
- Q21098868
- Methanesulfonamide, N-(1,4-dihydro-7-(1-methylethyl)-6-(1-methyl-1H-pyrazol-5-yl)-2,4-dioxo-3(2H)-quinazolinyl)-
- Methanesulfonamide, N-[1,4-dihydro-7-(1-methylethyl)-6-(1-methyl-1H-pyrazol-5-yl)-2,4-dioxo-3(2H)-quinazolinyl]-
- N-[7-isopropyl-6-(2-methyl-2H-pyrazol-3-yl)-2,4-dioxo-1,4-dihydro-2H-quinazolin-3-yl]-methanesulfonamide
- N-[6-(2-methylpyrazol-3-yl)-2,4-dioxo-7-propan-2-yl-1H-quinazolin-3-yl]methanesulfonamide
- Methanesulfonamide,N-[1,4-dihydro-7-(1-methylethyl)-6-(1-methyl-1H-pyrazol-5-yl)-2,4-dioxo-3(2H)-quinazolinyl]-
- N-(1,4-Dihydro-7-(1-methylethyl)-6-(1-methyl-1H-pyrazol-5-yl)-2,4-dioxo-3(2H)-quinazolinyl)methanesulfonamide
- N-(6-(1-methyl-1H-pyrazol-5-yl)-2,4-dioxo-7-(propan-2-yl)-1,2,3,4-tetrahydroquinazolin-3-yl)methanesulfonamide
- N-(6-(1-METHYL-1H-PYRAZOL-5-YL)-7-(PROPAN-2-YL)-2,4-DIOXO-1,4-DIHYDROQUINAZOLIN-3(2H)-YL)METHANESULFONAMIDE
- N-(7-isopropyl-6-(1-methyl-1H-pyrazol-5-yl)-2,4-dioxo-1,2-dihydroquinazolin-3(4H)-yl)methanesulfonamide
- N-[6-(1-Methyl-1H-pyrazol-5-yl)-2,4-dioxo-7-(propan-2-yl)-1,4-dihydroquinazolin-3(2H)-yl]methanesulfonamide